X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://investors.merrimack.com/news-releases/news-release-details/merrimack-reports-ipsen-announcement-approval-us-fda-onivyder
https://www.globenewswire.com/news-release/2023/06/14/2688483/0/en/Correction-Ipsen-announces-U-S-FDA-submission-acceptance-of-its-supplemental-New-Drug-Application-for-Onivyde-regimen-in-first-line-metastatic-pancreatic-ductal-adenocarcinoma.html
https://www.prnewswire.com/news-releases/edison-oncology-announces-presentation-of-two-scientific-posters-at-aacr-annual-meeting-301803139.html
https://www.fiercepharma.com/pharma/ipsens-onivyde-proves-its-worth-previously-untreated-specific-pancreatic-cancer
https://www.prnewswire.com/news-releases/rrx-001--irinotecan-significantly-improved-progression-free-survival-pfs-versus-regorafenib-in-the-randomized-phase-2-rocket-trial-in-advanced-colorectal-cancer-301702337.html
https://www.biospace.com/article/ipsen-plans-to-file-snda-for-onivyde-in-mpdac-following-positive-phase-iii-results/
https://pharmaphorum.com/news/phase-3-lung-cancer-fail-dents-prospects-of-ipsen-serviers-onivyde/
https://www.clinicaltrialsarena.com/news/epicentrx-paediatric-cns-tumour-treatment/
https://www.prnewswire.com/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-initiation-of-confirmatory-phase-3-clinical-trial-of-zepzelca-lurbinectedin-for-the-treatment-of-patients-with-relapsed-small-cell-lung-cancer-301442832.html
https://www.fiercepharma.com/marketing/michael-landon-s-daughter-urges-genetic-testing-for-pancreatic-cancer-risk-psa
https://www.fiercepharma.com/pharma/ipsen-poaches-novartis-vet-mari-scheiffele-to-serve-as-president-its-international-specialty
https://www.biospace.com/article/releases/cardiff-oncology-announces-first-patient-dosed-in-a-phase-2-trial-of-onvansertib-in-combination-with-irinotecan-and-5-fu-in-pancreatic-cancer/
https://www.globenewswire.com/news-release/2021/06/07/2242640/0/en/Salarius-Pharmaceuticals-Presents-New-Research-Data-Demonstrating-Seclidemstat-s-Safety-Dosing-and-Drug-Activity-at-American-Society-of-Clinical-Oncology-ASCO-2021-Annual-Meeting.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213278
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-24-2020-1592990703.pdf
https://braintumorcenter.ucsf.edu/clinical-trial/pevonedistat-irinotecan-hydrochloride-and-temozolomide-treating-patients-recurrent
http://www.pharmatimes.com/news/success_for_enhertu_in_phase_ii_gastric_cancer_trial_1323583
https://www.fiercebiotech.com/biotech/after-exiting-troubled-merrimack-former-ceo-becomes-new-chief-at-yumanity
https://www.biospace.com/article/array-biopharma-s-triple-drug-combo-could-be-gamechanger-for-colorectal-cancer/
https://www.fiercebiotech.com/medtech/dotlab-nets-10m-for-its-blood-test-to-diagnose-endometriosis
https://www.businesswire.com/news/home/20190523005596/en/New-Investigational-Clinical-Data-Ipsen%E2%80%99s-Oncology-Products/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.prnewswire.com/news-releases/armas-pharmaceuticals-continues-to-add-to-portfolio-with-launch-of-second-oncology-injectable-300845224.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208718
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208718
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf
https://www.reuters.com/article/us-shire-m-a-servier/shire-sells-cancer-drugs-to-servier-for-2-4-billion-as-takeda-circles-idUSKBN1HN0P8
https://www.biospace.com/article/fda-accepts-bristol-myers-combo-application/
https://www.reuters.com/article/us-ipsen-strategy-interview/french-pharma-group-ipsen-sees-more-asset-purchases-u-s-growth-idUSKCN1FZ0YP
https://www.pharmacompass.com/pdf/news/five-drugs-suspended-after-factory-inspection-1509081498.pdf
http://www.fiercebiotech.com/biotech/merrimack-names-drummond-as-head-research-unit
http://www.pmlive.com/pharma_news/nice_knocks-back_shires_pancreatic_cancer_treatment_onivyde_1190176
http://www.pharmatimes.com/news/smc_welcomes_roches_gazyvaro_but_rejects_shires_onivyde_1188926
http://www.biospace.com/News/sanofi-genzyme-exec-jumps-ship-to-helm-merrimack/444429/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.pharmatimes.com/news/nice_rejects_shires_pancreatic_cancer_drug_1177060
http://www.pmlive.com/pharma_news/shire_wins_eu_licence_for_pancreatic_cancer_drug_onivyde_1169896
http://www.prnewswire.com/news-releases/onivyde-receives-positive-chmp-opinion-for-treatment-of-patients-with-metastatic-adenocarcinoma-of-the-pancreas-who-have-progressed-following-gemcitabine-based-therapy-588095922.html
http://www.prnewswire.com/news-releases/merrimack-and-baxalta-announce-initiation-of-phase-1-study-of-mm-151-in-combination-with-the-onivyde-irinotecan-liposome-injection-regimen-in-metastatic-colorectal-cancer-300271334.html
http://www.prnewswire.com/news-releases/pharmaengine-announces-korean-ministry-of-food-and-drug-safety-accepted-the-nda-filing-of-onivyder-for-the-treatment-of-metastatic-pancreatic-cancer-300266582.html
http://twofourinsight.com/approval-camptosar-anda-adds-more-competition-generic-market/
https://www.pharmacompass.com/pdf/news/qilu-pharms-generic-irinotecan-hcl-approved-in-us-as-an-antineoplastic-agent-1462534968.pdf
http://www.fiercepharmaasia.com/story/3sbio-gets-china-fda-ind-nod-peg-irinotecan-candidate/2016-03-07
Market Place
Share 
